Keystone Symposia Scientific Advisory Board

The Scientific Advisory Board (SAB) is comprised of eminent biomedical scientists whose expertise derives from academia, industry, and the government. The SAB is tasked with guiding the development of the conference portfolio, prioritizing content and topics, and providing a substantive peer review process to ensure Keystone Symposia's reputation as the preeminent convener of scientific conferences in the biomedical and life sciences.

To learn more about the functions of the SAB, please click here.

Board of Directors are denoted with a # following their name.

Dale Abel, M.D., Ph.D.#
Director F.O.E. Diabetes Research Center
Professor of Medicine and Biochemistry
University of Iowa, Carver College of Medicine

Clement Adebamowo, B.M., Ch.B., Hons, Sc.D.
Professor Epidemiology and Public Health
Associate Director Population Science,
Greenebaum Comprehensive Cancer Center
Member, Institute of Human Virology
University of Maryland School of Medicine

Luciano Adorini, M.D.
Chief Scientific Officer
Preclinical Research
Intercept Pharmaceuticals, Inc.

Heather A. Arnett, Ph.D.
Inflammation Research
Amgen Inc.

James E. Audia, Ph.D.
Chief Scientific Officer
Constellation Pharmaceuticals

Eric H. Baehrecke, Ph.D.
Department of Molecular, Cell and Cancer Biology
University of Massachusetts Medical School

Jacques F. Banchereau, Ph.D.
Professor and Director of Immunological Sciences
The Jackson Laboratory for Genomic Medicine

Carl Barrett, Ph.D.
Vice President, Translational Science
Oncology Innovative Medicines

Dominic P. Behan, Ph.D., D.Sc.
Co-Founder and Chair
Scientific Advisory Board
Arena Pharmaceuticals, Inc.

Ralph A. Bradshaw, Ph.D.#
Professor Emeritus
Department of Physiology and Biophysics
University of California, Irvine

Cherié L. Butts, Ph.D.#
Associate Director
Portfolio Leadership

Robert L. Coffman, Ph.D.
Senior Vice President and Chief Scientific Officer
Dynavax Technologies

Roger D. Cone, Ph.D.
Life Sciences Institute
University of Michigan

Rodrigo Corrêa-Oliveira, Ph.D.
Vice President
Research and Biological Collections

Russell A. DeBose-Boyd, Ph.D.
Molecular Genetics
University of Texas Southwestern Medical Center

Edward A. Dennis, Ph.D.#
Chemistry, Biochemistry and Pharmacology
School of Medicine
University of California, San Diego

Vishva M. Dixit, M.D.#
Vice President, Early Discovery Research and Physiological Chemistry
Genentech, Inc.

Aris N. Economides, Ph.D.
Vice President
Regeneron Pharmaceuticals, Inc.

Martin P. Edwards, Ph.D.
Vice President
Oncology Medicinal Chemistry
Cancer Research Chemistry
Pfizer La Jolla

Markus Enzelberger, Ph.D.
Senior Vice President
Discovery, Alliances and Technologies
MorphoSys AG

Peter M. Finan, Ph.D.#
Venture Partner
Epidarex Capital

Curt R. Freed, M.D.
Professor and Head
Division of Clinical Pharmacology and Toxicology
University of Colorado, Denver

Stacey Gabriel, Ph.D.
Senior Director
Genomics Platform
The Broad Institute

Adolfo García-Sastre, Ph.D.
Department of Microbiology
Mount Sinai School of Medicine

Tariq Ghayur, Ph.D.
Senior Research Fellow
AbbVie Inc.

Geoffrey S. Ginsburg, M.D., Ph.D.
Director, Center for Applied Genomics and Precision Medicine
Center for Applied Genomics and Center for Personalized and Precision Medicine
Duke University

Margaret A. Goodell, Ph.D.#
Professor; Director of Stem Cells & Regenerative Medicine Center
Baylor College of Medicine

Bryan Goodwin, PhD
Senior Director
Gastrointestinal, Metabolic, and Endocrine Therapeutic Area

Austin Gurney, Ph.D.
Senior Vice President, Molecular & Cellular Biology
OncoMed Pharmaceuticals, Inc.

Heidi E. Hamm, Ph.D.#
Department of Pharmacology
Vanderbilt University School of Medicine

Curtis C. Harris, M.D.#
Chief, Laboratory of Human Carcinogenesis
NCI / National Institutes of Health

Jacqueline E. Heard, Ph.D.

Sharath S. Hegde, Ph.D.
Senior Vice President, Research
Theravance Biopharma

Kim A. Heidenreich, Ph.D.
Professor Emeritus, University of Colorado School of Medicine
Scientific Director, Bioscience Biopharma Partners

De' Broski R. Herbert, Ph.D.
Associate Professor of Infectious Immunology
School of Veterinary Medicine
University of Pennyslvania

Linda Slanec Higgins, Ph.D.
Vice President , Biology
Gilead Sciences, Inc.

Sean Hill, Ph.D.
Blue Brain Project
École Polytechnique Fédérale de Lausanne (EPFL)

Steve Hitchcock, Ph.D.
Head of Research
Takeda Pharmaceuticals International Co.

Michael C. Holmes, Ph.D.
Vice President of Research
Sangamo Therapeutics, Inc.

Reid M. Huber, Ph.D.
Executive Vice President, Chief Scientific Officer
Discovery Biology
Incyte Corporation

Tony Hunter, Ph.D.
Professor, Molecular Biology and Cellular Biology Laboratory
The Salk Institute

Thale C. Jarvis, Ph.D.#
Chief Scientific Officer
Keystone Symposia

Allan R. Jones, Ph.D.
Chief Executive Officer
Allen Institute for Brain Science

Takashi Kadowaki, M.D., Ph.D.
Professor and Chairman
Graduate School of Medicine, Diabetes and Metabolic Diseases
University of Tokyo

Christopher L. Karp, M.D.
Deputy Director, Vaccines & Host-Pathogen Biology
Global Health Discovery & Translational Sciences
Bill & Melinda Gates Foundation

Laura L. Kiessling, Ph.D.
Hilldale Professor of Chemistry
Laurens Anderson Professor of Biochemistry
Department of Chemistry and Biochemistry
University of Wisconsin, Madison

Jacqueline Kirchner, Ph.D.

Karla A. Kirkegaard, Ph.D.
Violetta Horton Professor
Genetics & Microbiology & Immunology
Stanford University School of Medicine

Christian Klein, Ph.D.
Distinguished Scientist
Roche Pharmaceutical Research & Development
Roche Innovation Center Zürich
Roche Glycart AG

Martin Kussmann, Ph.D.
Professor, Systems Biology in Nutrition and Health
Liggins Institute, University of Auckland
Chief Scientist, High Value Nutrition
A New Zealand National Science Challenge

Jeffrey L. Kutok, M.D., Ph.D.
Chief Scientific Officer
Infinity Pharmaceuticals, Inc.

Tony K.T. Lam, Ph.D.
Professor and J.K. McIvor Endowed Chair in Diabetes Research
Canada Research Chair in Obesity
Associate Director, Banting and Best Diabetes Centre
Advanced Diagnostics and Metabolism
Toronto General Research Institute

John M. Lambert, Ph.D.
Executive Vice President and Distinguished Research Fellow
ImmunoGen, Inc.

Philip J. Larsen, Ph.D.
Global Head Diabetes Discovery and Early Clinical Development
R&D, Germany

Jan E. Leach, Ph.D.
University Distinguished Professor
Bioagricultural Sciences
Colorado State University

Hyam I. Levitsky, Ph.D.
Executive Vice President
Research & Chief Scientific Officer
Juno Therapeutics

Dangsheng Li, Ph.D.
Deputy Editor-in-Chief
Cell Research
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences

Juan Carlos Lopez, Ph.D.#
Head, Academic Relations and Collaborations
Pharmaceutical Research and Early Development

Timothy B. Lowinger, Ph.D.
Chief Scientific Officer
Mersana Therapeutics

Lamine Mbow, Ph.D.
Immunology & Inflammation
Boehringer Ingelheim

M. Juliana McElrath, M.D., Ph.D.
Senior Vice President, Director and Member
Vaccine and Infectious Disease Division
Fred Hutchinson Cancer Research Center

Elizabeth M. McNally, M.D., Ph.D.
Center for Genetic Medicine
Northwestern University Feinberg School of Medicine

Juanita L. Merchant, M.D., Ph.D.
Departments of Internal Medicine and Molecular and Integrative Physiology
University of Michigan

Tara Mirzadegan, Ph.D.
Senior Director
Janssen R&D: Pharmaceutical Companies of Johnson & Johnson

Craig Monell, Ph.D.
Vice President
Business Operations/R&D
BioLegend, Inc.

Walter H. Moos, Ph.D.#
President (ret.), SRI Biosciences
Professor (adj.), University of California San Francisco

Dominik Mumberg, Ph.D.
Director, Cell Cycle & Survival Signaling Research
Global Drug Discovery
Bayer HealthCare

Leon O. Murphy, Ph.D.
Novartis Pharmaceuticals

Vic E. Myer, Ph.D.
Chief Technology Officer
Editas Medicine, Inc.

Gary J. Nabel, M.D., Ph.D.#
Chief Scientific Officer
Research and Development

Steven G. Nadler, Ph.D.
Group Director
Translational Research Immuno-Sciences
Biology Drug Discovery
Bristol-Myers Squibb Company

Anne O'Garra, Ph.D., FRS, FMedSci#
Associate Research Director
The Francis Crick Institute
Mill Hill Laboratory

Gary Paul O'Neill, Ph.D.
Vice President, Biology and Drug Discovery
Department of Biology and Drug Discovery
Abide Therapeutics Inc.

Eric M. Parker, Ph.D.
Independent Pharmaceutical Consultant

Paul W. H. I. Parren, Ph.D.
Senior Vice President and Scientific Director
Genmab B.V.

Jane L. Peterson, Ph.D.#
President and Chief Executive Officer
Keystone Symposia

Roberto D. Polakiewicz, Ph.D.
Chief Scientific Officer
Cell Signaling Technology, Inc.

Mark Powers, Ph.D.
Senior Director, Research and Development
Cell Biology
Thermo Fisher Scientific

Bali Pulendran, Ph.D.
Emory Vaccine Center
Emory University

Laszlo Radvanyi, Ph.D.
Senior Vice President, Global Head of Immuno-Oncology R&D
Immuno-Oncology Translational Innovation Platform
EMD Serono / Merck KgaA, Darmstadt Germany

Ronald Raines, Ph.D.
Departments of Biochemistry and Chemistry
University of Wisconsin - Madison

Bing Ren, Ph.D.
Ludwig Institute for Cancer Research

Cristina M. Rondinone, Ph.D.
Vice President, Research and Development
Head, Cardiovascular and Metabolic Diseases
MedImmune, Inc.

Kei Sakamoto, Ph.D.
Head, Diabetes and Circadian Rhythms
Nestlé Institute of Health Sciences

Alejandro Sánchez Alvarado, Ph.D.
Stowers Institute for Medical Research/HHMI

Terrence J. Sejnowski, Ph.D.
Computational Neurobiology Laboratory
The Salk Institute

Ali Shilatifard, Ph.D.
Robert Francis Furchgott Professor
Chairman, Department of Biochemistry and Molecular Genetics
Northwestern University Feinberg School of Medicine

Frank J. Slack, Ph.D.
Institute for RNA Medicine
BIDMC Cancer Center/Harvard Medical School

Barry P. Sleckman, M.D., Ph.D.
Vice Chair for Research
Pathology and Laboratory Medicine
Weill Cornell Medical College

Hans Ulrich Stilz, Ph.D.
Vice President
R&D Academic Partnerships
Novo Nordisk A/S

Lynda M. Stuart, M.D., Ph.D.
Senior Program Officer
Global Health, Discovery & Translational Sciences
Bill & Melinda Gates Foundation

Eric E. Swayze, Ph.D.
Vice President
Medicinal Chemistry
Ionis Pharmaceuticals

Paul K.H. Tam, ChM
Provost and Deputy Vice-Chancellor
Li Shu-Pui Professor and Chair of Pediatric Surgery
The University of Hong Kong

Cormac Taylor, Ph.D.
Professor of Cellular Physiology
University College Dublin

Fred Van Goor, Ph.D.
Principal Research Fellow
Vertex Pharmaceuticals Incorporated

Joanne L. Viney, Ph.D.
JLV Biotech Consulting

Michael J.O. Wakelam, Ph.D.
Institute Director
The Babraham Institute

Bruce D. Walker, M.D.#
Ragon Institute of MGH, MIT & Harvard
Ragon Institute

Yibin Wang, Ph.D.
Anesthesiology, Physiology and Medicine
University of California, Los Angeles
David Geffen School of Medicine

Andrew B. Ward, Ph.D.
Associate Professor
Integrative Structural and Computational Biology
The Scripps Research Institute

Stephanie Wengert Watts, Ph.D.
Professor, Assistant Dean
Pharmacology & Toxicology
Michigan State University

Keith M. Wilcoxen, Ph.D.
Senior Director
Scientific Research and Development

Ian A. Wilson, Ph.D., Sc.D., FRS#
Professor and Chair,
Integrative Structural and Computational Biology
The Scripps Research Institute

Peter J. Worland, Ph.D.
Vice President, Integrative Research Development
Executive Research
Celgene Corporation

Joseph C. Wu, M.D., Ph.D.
Professor and Director of Stanford Cardiovascular Institute
Medicine and Radiology
Stanford University School of Medicine

Tadataka Yamada, M.D.#
Managing Partner
Mountain Field LLC

Xuebiao Yao, Ph.D.
Professor and Head
Cellular Dynamics
University of Science & Technology of China

Bei B. Zhang, Ph.D.#
General Manager, Lilly China Research & Development Co., Ltd. (LCRDC)
Vice President, Lilly Research Laboratories
Eli Lilly & Company

Juleen R. Zierath, Ph.D.#
Molecular Medicine and Surgery
Karolinska Institutet

Michael J. Zigmond, Ph.D.
Professor of Neurology, Psychiatry and Behavioral and Community Health Sciences
University of Pittsburgh

plus representatives to be announced from:
Merck & Co., Inc.
Moderna Therapeutics